scholarly journals Disparities in adversity among children with autism spectrum disorder: a population-based study

2016 ◽  
Vol 58 (11) ◽  
pp. 1124-1131 ◽  
Author(s):  
Kristin L Berg ◽  
Cheng-Shi Shiu ◽  
Kruti Acharya ◽  
Bradley C Stolbach ◽  
Michael E Msall
2016 ◽  
Vol 46 (11) ◽  
pp. 3607-3614 ◽  
Author(s):  
Gnakub N. Soke ◽  
Steven A. Rosenberg ◽  
Richard F. Hamman ◽  
Tasha Fingerlin ◽  
Cordelia Robinson ◽  
...  

2019 ◽  
Vol 50 (2) ◽  
pp. 625-633 ◽  
Author(s):  
Basmah H. Alfageh ◽  
Kenneth K. C. Man ◽  
Frank M. C. Besag ◽  
Tariq M. Alhawassi ◽  
Ian C. K. Wong ◽  
...  

Abstract Autism spectrum disorder (ASD) is a lifelong disorder. In the UK, risperidone is the only psychotropic medication approved for the management of the behavioural symptoms that may accompany autism. This is a population-based study aimed to provide an evaluation of the changing trend in the incidence and prevalence of ASD and to analyse the pattern of psychotropic medication prescribing in the UK. 20,194 patients with ASD were identified. The prevalence increased 3.3-fold from 0.109 per 100 persons in 2009 to 0.355 per 100 persons in 2016. Approximately one-third of the identified cohort was prescribed at least one psychotropic medication. Although the medications approved to manage the symptoms of ASD are limited, the prescribing of such medications is increasing.


2019 ◽  
Vol 61 (2) ◽  
pp. 131-139 ◽  
Author(s):  
Gillian M. Maher ◽  
Gerard W. O'Keeffe ◽  
Christina Dalman ◽  
Patricia M. Kearney ◽  
Fergus P. McCarthy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document